Neuropsychiatric symptoms as a prodromal factor in Alzheimer's type neurodegenerative disease: a scoping review.

Objective: Identifying neuropsychiatric symptoms (NPS) can aid in the early detection of Alzheimer's disease (AD); however, there is still a need for a greater consensus. This review aims to delineate the predominant NPS, compile a comprehensive list of the most commonly employed NPS assessment tools, and corroborate the principal findings regarding the link between NPS and neuropsychological assessment and neurobiological substrates. Methods: To conduct this scoping review, we followed the Preferred Reporting Items for Systematic Reviews guidelines and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR). We searched for relevant articles published between 2017 and 2023 in MEDLINE, PsycINFO, PubMed, Web of Science, and Cochrane Library. Results: Of the 61 eligible articles, depression, anxiety, and apathy were the main NPSs. The Neuropsychiatric Inventory Questionnaire and Neuropsychiatric Inventory were the primary assessment tools used to evaluate NPS. Correlations between NPS severity and neurobiological markers were considered clinically significant. Furthermore, clinical procedures prioritized the use of global cognitive screening tools, assessments of executive functions, and functionality evaluations. Conclusion: Standardization of procedures is necessary because of the diversity of methods. The data show that NPS can predict the etiology, severity, form, and type of disease progression, serving as a precursor sign of AD. The results of the most common cognitive screening tools and NPS instruments provided an interesting overview of future clinical approaches.

Influence of cerebral blood flow on volumetric loss related to Alzheimer's disease.

CBF measured with Arterial Spin Labeling (ASL) obtained by Magnetic Resonance Imaging (MRI) may become an important biomarker by showing changes in early stages of AD, such as in the prodromal stage of Mild Cognitive Impairment (MCI). Objective: Verify the correlation between atrophy and CBF in patients with MCI and mild phase ADD, to demonstrate whether changes in CBF can be considered as vascular biomarkers in the diagnosis of the DA continuum. Methods: 11 healthy volunteers, 16 MCI and 15 mild ADD were evaluated. Images of the brain were acquired, including CBF measured with Arterial Spin Labeling (ASL). Results: When comparing MCI with control, a reduction in normalized CBF was observed in left posterior cingulate (estimated difference -0.38; p=0.02), right posterior cingulate (estimated difference -0.45; p=0.02) and right precuneus (estimated difference -0.28; p <0.01); also increase in normalized CBF in right upper temporal pole (estimated difference 0.22; p=0.03). It was also observed that in MCI, the smaller the gray matter volume, the smaller the CBF in the left posterior cingulate; as well as the greater the cerebrospinal fluid volume, consequent to the encephalic volumetric reduction associated with atrophy, the greater the CBF in the right superior temporal pole. When comparing controls, MCI and mild AD, in relation to the other variables, no other correlations were observed between CBF and atrophy. Conclusion: In patients with MCI, the reduction of CBF in the left posterior cingulate correlated with gray matter atrophy, as well as the increase of CBF in the right upper temporal pole correlated with an increase in cerebrospinal fluid consequent to the encephalic volumetric reduction associated with atrophy, demonstrating the influence of CBF in AD related brain atrophy. These findings position CBF as a possible vascular biomarker for early-stage AD diagnoses.

A imagem por ressonância magnética (IRM) pode se tornar um importante biomarcador ao mostrar alterações nos estágios iniciais da doença de Alzheimer (DA). Objetivo: Sendo a atrofia cerebral um importante biomarcador de neurodegeneração na DA, o presente estudo foi realizado com o objetivo de verificar se há correlação entre atrofia e fluxo sanguíneo cerebral (FSC) em pacientes com diagnóstico de CCL e demência da doença de Alzheimer (DDA) leve, com o objetivo de revelar se as alterações no FSC podem ser consideradas possíveis biomarcadores vasculares no diagnóstico do continuum da DA. Métodos: Foram avaliados 11 voluntários saudáveis, 16 CCL e 15 DDA leve. Imagens do cérebro foram adquiridas em um equipamento de 3 T, incluindo imagens ponderadas em T1 de alta resolução para avaliação anatômica e Arterial Spin Labeling (ASL) para a quantificação de FSC. Resultados: Quando comparado CCL com controle, observou-se redução no FSC normalizado em cingulado posterior esquerdo (diferença estimada de -0,38; p=0,02), cingulado posterior direito (diferença estimada de -0,45; p=0,02) e precúneo direito (diferença estimada de -0,28; p <0,01); e aumento de FSC normalizado no polo temporal superior direito (diferença estimada de 0,22; p=0,03). No CCL, quanto menor o volume da substância cinzenta, menor o FSC no cingulado posterior esquerdo; quanto maior o volume de fluido cerebroespinhal, consequente à redução volumétrica encefálica, maior o FSC no polo temporal superior direito. Conclusão: Nos pacientes com diagnóstico de CCL, a redução de FSC no cingulado posterior esquerdo apresentou correlação com atrofia da substância cinzenta, assim como o aumento de FSC no polo temporal superior direito apresentou correlação com o aumento de fluido cerebroespinhal, demonstrando a provável influência do FSC na atrofia encefálica relacionada à DA.

Influence of cerebral blood flow on volumetric loss related to Alzheimer's disease / Influência do fluxo sanguíneo cerebral na perda volumétrica relacionada à doença de Alzheimer

ABSTRACT: CBF measured with Arterial Spin Labeling (ASL) obtained by Magnetic Resonance Imaging (MRI) may become an important biomarker by showing changes in early stages of AD, such as in the prodromal stage of Mild Cognitive Impairment (MCI). Objective: Verify the correlation between atrophy and CBF in patients with MCI and mild phase ADD, to demonstrate whether changes in CBF can be considered as vascular biomarkers in the diagnosis of the DA continuum. Methods: 11 healthy volunteers, 16 MCI and 15 mild ADD were evaluated. Images of the brain were acquired, including CBF measured with Arterial Spin Labeling (ASL). Results: When comparing MCI with control, a reduction in normalized CBF was observed in left posterior cingulate (estimated difference -0.38; p=0.02), right posterior cingulate (estimated difference -0.45; p=0.02) and right precuneus (estimated difference -0.28; p <0.01); also increase in normalized CBF in right upper temporal pole (estimated difference 0.22; p=0.03). It was also observed that in MCI, the smaller the gray matter volume, the smaller the CBF in the left posterior cingulate; as well as the greater the cerebrospinal fluid volume, consequent to the encephalic volumetric reduction associated with atrophy, the greater the CBF in the right superior temporal pole. When comparing controls, MCI and mild AD, in relation to the other variables, no other correlations were observed between CBF and atrophy. Conclusion: In patients with MCI, the reduction of CBF in the left posterior cingulate correlated with gray matter atrophy, as well as the increase of CBF in the right upper temporal pole correlated with an increase in cerebrospinal fluid consequent to the encephalic volumetric reduction associated with atrophy, demonstrating the influence of CBF in AD related brain atrophy. These findings position CBF as a possible vascular biomarker for early-stage AD diagnoses.

RESUMO: A imagem por ressonância magnética (IRM) pode se tornar um importante biomarcador ao mostrar alterações nos estágios iniciais da doença de Alzheimer (DA). Objetivo: Sendo a atrofia cerebral um importante biomarcador de neurodegeneração na DA, o presente estudo foi realizado com o objetivo de verificar se há correlação entre atrofia e fluxo sanguíneo cerebral (FSC) em pacientes com diagnóstico de CCL e demência da doença de Alzheimer (DDA) leve, com o objetivo de revelar se as alterações no FSC podem ser consideradas possíveis biomarcadores vasculares no diagnóstico do continuum da DA. Métodos: Foram avaliados 11 voluntários saudáveis, 16 CCL e 15 DDA leve. Imagens do cérebro foram adquiridas em um equipamento de 3 T, incluindo imagens ponderadas em T1 de alta resolução para avaliação anatômica e Arterial Spin Labeling (ASL) para a quantificação de FSC. Resultados: Quando comparado CCL com controle, observou-se redução no FSC normalizado em cingulado posterior esquerdo (diferença estimada de -0,38; p=0,02), cingulado posterior direito (diferença estimada de -0,45; p=0,02) e precúneo direito (diferença estimada de -0,28; p <0,01); e aumento de FSC normalizado no polo temporal superior direito (diferença estimada de 0,22; p=0,03). No CCL, quanto menor o volume da substância cinzenta, menor o FSC no cingulado posterior esquerdo; quanto maior o volume de fluido cerebroespinhal, consequente à redução volumétrica encefálica, maior o FSC no polo temporal superior direito. Conclusão: Nos pacientes com diagnóstico de CCL, a redução de FSC no cingulado posterior esquerdo apresentou correlação com atrofia da substância cinzenta, assim como o aumento de FSC no polo temporal superior direito apresentou correlação com o aumento de fluido cerebroespinhal, demonstrando a provável influência do FSC na atrofia encefálica relacionada à DA.

Comprometimentos cognitivos na Diabetes Mellitus Tipo 1: revisão integrativa / Cognitive impairments in Type 1 Diabetes Mellitus: integrative review / Deficiencias cognitivas en la Diabetes Mellitus Tipo 1: revisión integradora

This review verified cognitive domains affected by type 1 diabetes mellitus (T1DM) and the instruments used for its assessment. We performed a search in three databases using the descriptors "type 1 diabetes" AND "cognitive dysfunction". Only six of the 120 articles found met the criteria for inclusion in the review. The anal-ysis of these articles indicates that the main cognitive functions compromised by T1DM are attention, visual attention, verbal memory, immediate and late recovery, and psychomotor speed. Among the selected articles, we found that the most used instruments were the Montreal Cognitive Assessment (MoCA), the Wechsler scales (WMS-III and WMS-RC), the Trail Making Test, The Grooved Pegboard, and substitution (letter-symbol, digit-symbol). Due to the different impairments found, we suggest the importance of standardizing a battery of cognitive assessments and greater efforts to understand the functional impairments resulting from dam-age to cognition in individuals with T1DM

Esta revisão verificou os domínios cognitivos afetados pela diabetes mellitus tipo 1 (type 1 diabetes mellitus [T1DM]). Realizamos busca em três bases de dados, utilizando os descritores "type 1 diabetes" AND "cognitive dysfunction". Apenas seis dos 120 artigos encontrados cumpriram critérios para inclusão na revisão. A análise desses artigos indica que as principais funções cognitivas comprometidas pela T1DM são atenção, atenção vi-sual, memória verbal, recuperação imediata e tardia e velocidade psicomotora. Nos artigos selecionados, veri-ficamos que os instrumentos mais utilizados foram o Montreal Cognitive Assessment (MoCA), as escalas Wechs-ler (WMS-III e WMS-RC), o Teste de Trilhas, The Grooved Pegboard e substituição (letra-símbolo, dígito-símbolo). Em virtude dos diferentes comprometimentos encontrados, sugerimos a importância da padronização de uma bateria de avaliações cognitivas e maiores esforços na compreensão dos prejuízos funcionais decorrentes dos danos à cognição em indivíduos com T1DM.

Esta revisión analizó los dominios cognitivos afectados por la diabetes mellitus tipo 1 (type 1 diabetes mellitus [T1DM]) y los instrumentos utilizados para su evaluación. Se realizó una búsqueda en tres bases de datos, utili-zando los descriptores "type 1 diabetes" AND "cognitive dysfunction". Solo seis de los 120 artículos encontra-dos cumplieron los criterios para su inclusión en la revisión. El análisis de estos artículos indica que las principa-les funciones cognitivas comprometidas por la TDM1 son la atención, la atención visual, la memoria verbal, la recuperación inmediata y tardía y la velocidad psicomotora. Entre los artículos seleccionados, encontramos que los instrumentos más utilizados fueron la Montreal Cognitive Assessment (MoCA), las escalas Wechsler (WMS-III y WMS-RC), la Prueba de Rastro, The Grooved Pegboard y la sustitución (letra-símbolo, dígito-símbo-lo). Debido a las diferentes deficiencias encontradas, sugerimos la importancia de estandarizar una batería de evaluaciones cognitivas y mayores esfuerzos para comprender las deficiencias funcionales que resultan del daño a la cognición en personas con TDM1.

Circulating Endocannabinoids in Huntington's Disease: An Exploratory Cross-Sectional Study.

Huntington's disease (HD) is an inherited neurodegenerative disease characterized by motor, cognitive and behavioral deficits. Some evidence suggests that the endocannabinoid system participates in the pathophysiology of HD. We conducted a cross-sectional study comparing plasma levels of anandamide and 2-arachidonoylglycerol in manifest HD gene-expansion carriers (HDGEC) and healthy controls, finding no difference in endocannabinoid levels between the groups. Correlations between endocannabinoid levels and clinical scales (Mini-Mental State Examination, Hospital Anxiety and Depression Scale, Unified Huntington Disease Rating Scale) were non-significant. We found a significant association between body mass index and anandamide levels in healthy controls but not in HDGEC.

COVID-19 pandemic and mental health of a sample of Brazilian caregivers of people with dementia / Pandemia de COVID-19 e saúde mental de uma amostra de cuidadores brasileiros de pessoas com demência

ABSTRACT Social distancing policies adopted in the COVID-19 pandemic generated a negative psychological impact on the general population and can affect caregivers of people with dementia more severely. Objective: This study screened for indications of mental health problems among informal caregivers of people with dementia. Main changes in the people's routine and behavior resulting from the social isolation measures adopted due to the pandemic were also investigated. Method: Thirty-five informal caregivers of people with dementia from a medium-sized Brazilian city responded to a telephone interview. Results: Risks for mental health problems were found in 31.4% of the sample. These participants stated that they found it very difficult to deal with routine care changes during the pandemic. The variables related to the caregiver's characteristics and those related to changes in routine significantly affected the caregiver's mental health scores. Discussion: Indices of mental disorders in the studied sample did not differ from the prevalence of mental health problems in the general population during COVID-19 pandemic; however, participants reported worsening symptoms such as nervousness, sadness, and sleep during quarantine. Conclusions: Results show the complexity of this topic and the need for individual care for this group, especially in situations like the COVID-19 pandemic.

RESUMO As medidas de isolamento social adotadas na pandemia de COVID-19 geraram um impacto psicológico negativo na população em geral e podem afetar mais duramente cuidadores de pessoas com demência. Objetivos: Esta pesquisa rastreou indicativos de problemas de saúde mental entre cuidadores informais de pacientes com demência. As principais modificações de rotina e comportamento dos pacientes decorrentes das medidas de isolamento social adotadas em função da pandemia também foram investigadas. Métodos: Trinta e cinco cuidadoras informais de pessoas com demência de uma cidade brasileira de médio porte responderam a uma entrevista por telefone. Resultados: Riscos de problemas de saúde mental foram encontrados em 31,4% da amostra. Esses participantes afirmaram encontrar muitas dificuldades para lidar com as mudanças de rotina de cuidados durante a pandemia. As variáveis relativas às características do cuidador e as relativas às alterações de rotina afetaram significativamente os escores de saúde mental do cuidador. Discussão: Os índices de indicadores de risco para problemas mentais na amostra não diferiram da população em geral durante a pandemia de COVID-19, mas os participantes relataram piora de sintomas como nervosismo, tristeza e sono durante a quarentena. Conclusões: Os resultados apresentados mostram a complexidade do tema e a necessidade de cuidados especiais para cuidadores de pessoas com demência, especialmente em situações como a pandemia de COVID-19.

COVID-19 pandemic and mental health of a sample of Brazilian caregivers of people with dementia.

Social distancing policies adopted in the COVID-19 pandemic generated a negative psychological impact on the general population and can affect caregivers of people with dementia more severely. Objective: This study screened for indications of mental health problems among informal caregivers of people with dementia. Main changes in the people's routine and behavior resulting from the social isolation measures adopted due to the pandemic were also investigated. Method: Thirty-five informal caregivers of people with dementia from a medium-sized Brazilian city responded to a telephone interview. Results: Risks for mental health problems were found in 31.4% of the sample. These participants stated that they found it very difficult to deal with routine care changes during the pandemic. The variables related to the caregiver's characteristics and those related to changes in routine significantly affected the caregiver's mental health scores. Discussion: Indices of mental disorders in the studied sample did not differ from the prevalence of mental health problems in the general population during COVID-19 pandemic; however, participants reported worsening symptoms such as nervousness, sadness, and sleep during quarantine. Conclusions: Results show the complexity of this topic and the need for individual care for this group, especially in situations like the COVID-19 pandemic.

As medidas de isolamento social adotadas na pandemia de COVID-19 geraram um impacto psicológico negativo na população em geral e podem afetar mais duramente cuidadores de pessoas com demência. Objetivos: Esta pesquisa rastreou indicativos de problemas de saúde mental entre cuidadores informais de pacientes com demência. As principais modificações de rotina e comportamento dos pacientes decorrentes das medidas de isolamento social adotadas em função da pandemia também foram investigadas. Métodos: Trinta e cinco cuidadoras informais de pessoas com demência de uma cidade brasileira de médio porte responderam a uma entrevista por telefone. Resultados: Riscos de problemas de saúde mental foram encontrados em 31,4% da amostra. Esses participantes afirmaram encontrar muitas dificuldades para lidar com as mudanças de rotina de cuidados durante a pandemia. As variáveis relativas às características do cuidador e as relativas às alterações de rotina afetaram significativamente os escores de saúde mental do cuidador. Discussão: Os índices de indicadores de risco para problemas mentais na amostra não diferiram da população em geral durante a pandemia de COVID-19, mas os participantes relataram piora de sintomas como nervosismo, tristeza e sono durante a quarentena. Conclusões: Os resultados apresentados mostram a complexidade do tema e a necessidade de cuidados especiais para cuidadores de pessoas com demência, especialmente em situações como a pandemia de COVID-19.

Profiles of cognitive impairment in the continuum from normal cognition to Alzheimer's clinical syndrome: Contributions of the short-term memory binding tests.

BACKGROUND: Short-term memory binding (STMB) tests assess conjunctive binding, in which participants should remember the integration of features, such as shapes (or objects) and colors, forming a unique representation in memory. In this study, we investigated two STMB paradigms: change detection (CD) and free recall (FR). OBJECTIVE: To investigate the cognitive profile in the CD and FR tasks of three diagnostic groups: cognitively unimpaired (CU), mild cognitive impairment (MCI), and Alzheimer's clinical syndrome (ACS). In addition, we aimed to calculate and compare the accuracy of the CD and FR tasks to identify MCI and ACS. METHODS: Participants were 24 CU, 24 MCI, and 37 ACS. The cognitive scores of the clinical groups were compared using analysis of variance (ANOVA) and receiver-operating characteristic (ROC) analyses were carried out to verify the accuracy of the STMB tasks. RESULTS: In the CD task, CU was different from MCI and ACS (CU > MCI = ACS), while in the FR task all groups were different (CU > MCI > ACS). The ROC analyses showed an area under the curve (AUC) of 0.855 comparing CU with MCI for the CD task and 0.975 for the FR. The AUC comparing CU and ACS was 0.924 for the CD and 0.973 for the FR task. The FR task showed better accuracy to identify MCI patients, and the same accuracy to detect ACS. CONCLUSION: The present findings indicate that impairments in CD and FR of bound representations are features of the cognitive profiles of MCI and ACS patients.

Direct and indirect assessment of functional abilities in patients with Parkinson's disease transitioning to dementia.

Cognitive impairment is common in patients with Parkinson's disease (PD), and evaluation of functional abilities is crucial for diagnosis of dementia. OBJECTIVE: We evaluated differences between direct and indirect functional assessment methods to evaluate functional abilities in PD patients. METHODS: We evaluated 32 patients with PD and suspected mild dementia using direct and indirect assessment methods. RESULTS: There was a significant difference between the scores of direct and indirect methods of assessment. Patients and close informants usually overestimated their abilities in many ADL. However, all functional assessment tools used in this study had a relatively good accuracy to predict abnormal performance in a global cognitive scale. Patients with normal cognition according to scores in a global cognitive scale may have some functional impairment in ADL. Direct Assessment of Functional Ability (DAFA) scores correlated linearly with scores in global cognitive scales, and especially with scores in the domains of memory and concentration. CONCLUSION: Patients and close informants usually overestimate their instrumental abilities in ADL. The direct assessment of daily functioning was more reliable than indirect tools to assess functional losses in patients with PD. Finally, some patients with PD but no dementia may present functional losses in ADL.

O comprometimento cognitivo é comum em pacientes com doença de Parkinson (DP), e a avaliação das habilidades funcionais é crucial para o diagnóstico de demência. OBJETIVO: Avaliamos diferenças entre os métodos de avaliação funcional direta e indireta para avaliar habilidades funcionais em pacientes com DP. MÉTODOS: Foram avaliados 32 pacientes com DP e suspeita de demência inicial usando métodos de avaliação direta e indireta. RESULTADOS: Houve uma diferença significativa entre os escores dos métodos diretos e indiretos de avaliação. Pacientes e informantes geralmente superestimaram suas habilidades em muitas atividades da vida diária (AVD). No entanto, todas as ferramentas de avaliação funcional utilizadas neste estudo tiveram uma precisão relativamente boa para prever desempenho anormal em uma escala cognitiva global. Pacientes com cognição normal, de acordo com os escores em uma escala cognitiva global, podem apresentar algum comprometimento funcional nas AVD. As pontuações do Direct Assessment of Functional Ability (DAFA) correlacionaram-se linearmente com as pontuações nas escalas cognitivas globais e, especialmente, com as pontuações nos domínios da memória e concentração. CONCLUSÃO: Pacientes e informantes próximos geralmente superestimam suas habilidades instrumentais nas AVD. A avaliação direta do funcionamento diário foi mais confiável do que ferramentas indiretas para avaliar perdas funcionais em pacientes com DP. Finalmente, alguns pacientes com DP, mas sem demência, podem apresentar perdas funcionais nas AVD.

Direct and indirect assessment of functional abilities in patients with Parkinsons disease transitioning to dementia / Avaliação direta e indireta das habilidades funcionais em pacientes com doença de parkinson em transição para demência

ABSTRACT. Cognitive impairment is common in patients with Parkinson's disease (PD), and evaluation of functional abilities is crucial for diagnosis of dementia. Objective: We evaluated differences between direct and indirect functional assessment methods to evaluate functional abilities in PD patients. Methods: We evaluated 32 patients with PD and suspected mild dementia using direct and indirect assessment methods. Results: There was a significant difference between the scores of direct and indirect methods of assessment. Patients and close informants usually overestimated their abilities in many ADL. However, all functional assessment tools used in this study had a relatively good accuracy to predict abnormal performance in a global cognitive scale. Patients with normal cognition according to scores in a global cognitive scale may have some functional impairment in ADL. Direct Assessment of Functional Ability (DAFA) scores correlated linearly with scores in global cognitive scales, and especially with scores in the domains of memory and concentration. Conclusion: Patients and close informants usually overestimate their instrumental abilities in ADL. The direct assessment of daily functioning was more reliable than indirect tools to assess functional losses in patients with PD. Finally, some patients with PD but no dementia may present functional losses in ADL.

RESUMO. O comprometimento cognitivo é comum em pacientes com doença de Parkinson (DP), e a avaliação das habilidades funcionais é crucial para o diagnóstico de demência. Objetivo: Avaliamos diferenças entre os métodos de avaliação funcional direta e indireta para avaliar habilidades funcionais em pacientes com DP. Métodos: Foram avaliados 32 pacientes com DP e suspeita de demência inicial usando métodos de avaliação direta e indireta. Resultados: Houve uma diferença significativa entre os escores dos métodos diretos e indiretos de avaliação. Pacientes e informantes geralmente superestimaram suas habilidades em muitas atividades da vida diária (AVD). No entanto, todas as ferramentas de avaliação funcional utilizadas neste estudo tiveram uma precisão relativamente boa para prever desempenho anormal em uma escala cognitiva global. Pacientes com cognição normal, de acordo com os escores em uma escala cognitiva global, podem apresentar algum comprometimento funcional nas AVD. As pontuações do Direct Assessment of Functional Ability (DAFA) correlacionaram-se linearmente com as pontuações nas escalas cognitivas globais e, especialmente, com as pontuações nos domínios da memória e concentração. Conclusão: Pacientes e informantes próximos geralmente superestimam suas habilidades instrumentais nas AVD. A avaliação direta do funcionamento diário foi mais confiável do que ferramentas indiretas para avaliar perdas funcionais em pacientes com DP. Finalmente, alguns pacientes com DP, mas sem demência, podem apresentar perdas funcionais nas AVD

Anatomic and neuropsychological findings in low-educated cognitively intact elderly from a Brazilian cohort.

In elderly individuals, low educational level may represent a risk factor for the development of dementia and a proxy of cognitive reserve. OBJECTIVE: This study examined the cognitive and neuroanatomic correlates of high versus low educational levels in cognitively healthy community-dwelling older adults in Brazil. METHODS: Fifty-three older adults (mean age: 68±5.3 years) were divided into a "low education" group [LE; 1-4 years of education (N=33)] and "high education" group [HE; >11 years of education (N=20)]. Both groups completed a comprehensive neuropsychological battery and underwent in vivo structural MRI close to the time of testing. RESULTS: Higher educational level increased the chance of having better scores on neuropsychological tests, including verbal and visual delayed recall of information, verbal learning, category fluency, global cognition, and vocabulary. Better scores on these tests were observed in the HE group relative to the LE group. Despite this, there were no group differences between MRI measures. CONCLUSION: Older adults with higher educational levels showed better scores on neuropsychological measures of cognition, highlighting the need for education-adjusted norms in developing countries. Given the absence of differences in structural anatomy between the groups, these findings appear to be best explained by theories of cognitive reserve.

Sabe-se que baixos níveis de educação são comuns em países em desenvolvimento. Em indivíduos idosos, em particular, baixos níveis de educação podem representar um fator de risco para o desenvolvimento de demência. Objetivo: Este estudo examina os correlatos cognitivos e neuroanatômicos de escolaridade alta versus baixa, em idosos cognitivamente saudáveis,vivendo em comunidade no Brasil. Métodos: Cinquenta e três idosos (média de idade: 68±5,3) foram divididos em um grupo de "baixa escolaridade" [LE; 1-4 anos de escolaridade (N=33)] e um grupo de "alta escolaridade" [HE; >11 anos de escolaridade (N=20)]. Ambos os grupos completaram uma bateria neuropsicológica abrangente e foram submetidos à RM estrutural in vivo próximo à testagem. Resultados: O nível educacional aumentou a chance de se obter melhores pontuações em testes neuropsicológicos, incluindo evocação verbal e visual da informação, aprendizagem verbal, fluência de categoria, cognição global e vocabulário. Escores mais altos foram encontrados no grupo HE, em detrimento do LE. Apesar disso, não houve diferenças entre os grupos nas medidas de ressonância magnética in vivo. Conclusão: Idosos com maiores níveis de escolaridade apresentaram melhores pontuações nas medidas neuropsicológicas da cognição, destacando a necessidade de normas ajustadas à educação nos países em desenvolvimento. Não havendo diferenças na anatomia estrutural entre os grupos, os achados parecem ser melhor explicados pelas teorias da "reserva cognitiva".

Anatomic and neuropsychological findings in low-educated cognitively intact elderly from a Brazilian cohort / Achados Anatômicos e Neuropsicológicos de Idosos Cognitivamente Saudáveis com Baixa Escolaridade em uma Coorte Brasileira

ABSTRACT In elderly individuals, low educational level may represent a risk factor for the development of dementia and a proxy of cognitive reserve. Objective: This study examined the cognitive and neuroanatomic correlates of high versus low educational levels in cognitively healthy community-dwelling older adults in Brazil. Methods: Fifty-three older adults (mean age: 68±5.3 years) were divided into a "low education" group [LE; 1-4 years of education (N=33)] and "high education" group [HE; >11 years of education (N=20)]. Both groups completed a comprehensive neuropsychological battery and underwent in vivo structural MRI close to the time of testing. Results: Higher educational level increased the chance of having better scores on neuropsychological tests, including verbal and visual delayed recall of information, verbal learning, category fluency, global cognition, and vocabulary. Better scores on these tests were observed in the HE group relative to the LE group. Despite this, there were no group differences between MRI measures. Conclusion: Older adults with higher educational levels showed better scores on neuropsychological measures of cognition, highlighting the need for education-adjusted norms in developing countries. Given the absence of differences in structural anatomy between the groups, these findings appear to be best explained by theories of cognitive reserve.

RESUMO Sabe-se que baixos níveis de educação são comuns em países em desenvolvimento. Em indivíduos idosos, em particular, baixos níveis de educação podem representar um fator de risco para o desenvolvimento de demência. Objetivo: Este estudo examina os correlatos cognitivos e neuroanatômicos de escolaridade alta versus baixa, em idosos cognitivamente saudáveis,vivendo em comunidade no Brasil. Métodos: Cinquenta e três idosos (média de idade: 68±5,3) foram divididos em um grupo de "baixa escolaridade" [LE; 1-4 anos de escolaridade (N=33)] e um grupo de "alta escolaridade" [HE; >11 anos de escolaridade (N=20)]. Ambos os grupos completaram uma bateria neuropsicológica abrangente e foram submetidos à RM estrutural in vivo próximo à testagem. Resultados: O nível educacional aumentou a chance de se obter melhores pontuações em testes neuropsicológicos, incluindo evocação verbal e visual da informação, aprendizagem verbal, fluência de categoria, cognição global e vocabulário. Escores mais altos foram encontrados no grupo HE, em detrimento do LE. Apesar disso, não houve diferenças entre os grupos nas medidas de ressonância magnética in vivo. Conclusão: Idosos com maiores níveis de escolaridade apresentaram melhores pontuações nas medidas neuropsicológicas da cognição, destacando a necessidade de normas ajustadas à educação nos países em desenvolvimento. Não havendo diferenças na anatomia estrutural entre os grupos, os achados parecem ser melhor explicados pelas teorias da "reserva cognitiva".

The Prevalence and Correlation of Non-motor Symptoms in Adult Patients with Idiopathic Focal or Segmental Dystonia.

Background: Idiopathic focal dystonia is a motor syndrome associated with dysfunction of basal ganglia circuits. Observations have suggested that many other non-motor symptoms may also be part of the clinical picture. The aim was to assess the prevalence and correlation of non-motor symptoms in patients with common idiopathic focal or segmental dystonia. Methods: In a single-center cross-sectional case-control study, we evaluated the presence of pain, neuropsychiatric symptoms, and sleep alterations in 28 patients with blepharospasm, 28 patients with cervical dystonia, 24 patients with writer's cramp, and 80 control subjects matched for sex, age, and schooling. We obtained clinical and demographic data, and evaluated patients using the Fahn-Marsden Dystonia Rating Scale and other specific scales for dystonia. All subjects completed the following questionnaires: Beck Depression Inventory, Beck Anxiety Inventory, Social Phobia Inventory, Apathy Scale, Epworth Sleepiness Scale, Pittsburgh Sleep Quality Index, Brief Pain Scale, and the World Health Organization Quality of Life brief scale. Results: The patients presented more symptoms of depression, anxiety, and apathy than the control subjects. They also reported worse quality of sleep and more pain complaints. Patients with blepharospasm were the most symptomatic subgroup. The patients had worse quality of life, and the presence of pain and symptoms of apathy and depression were the main influences for these findings, but not the severity of motor symptoms. Discussion: Patients with dystonia, especially those with blepharospasm, showed higher prevalence of symptoms of depression, anxiety, apathy, worse quality of sleep, and pain. These symptoms had a negative impact on their quality of life.

Recalling feature bindings differentiates Alzheimer's disease from frontotemporal dementia.

It has been challenging to identify clinical cognitive markers that can differentiate patients with Alzheimer's disease (AD) from those with behavioral variant frontotemporal dementia (bvFTD). The short-term memory binding (STMB) test assesses the ability to integrate colors and shapes into unified representations and to hold them temporarily during online performance. The objective of this study is to investigate whether free recall deficits during short-term memory binding (STMB) test can differentiate patients with AD from those with bvFTD and controls. Participants were 32 cognitively intact adults, 35 individuals with AD and 18 with bvFTD. All patients were in the mild dementia stage. Receiver-operating characteristic (ROC) analyses were used to examine the diagnostic accuracy of the STMB. The results showed that AD patients performed significantly worse than controls and bvFTD patients in the STMB test, while the latter groups showed equivalent performance. The bound condition of the STMB test showed an AUC of 0.853, with 84.4% of sensitivity and 80% of specificity to discriminate AD from controls and an AUC of 0.794, with 72.2% of sensitivity and 80% of specificity to differentiate AD from bvFTD. Binding deficits seem specific to AD. The free recall version of the STMB test can be used for clinical purposes and may aid in the differential diagnosis of AD. Findings support the view that the STMB may be a suitable cognitive marker for AD.

Neuropsychological changes in melancholic and atypical depression: A systematic review.

There is not a consensus as to whether neuropsychological profiling can distinguish depressive subtypes. We aimed to systematically review and critically analyse the literature on cognitive function in patients with melancholic and atypical depression. We searched in databases PubMed, SCOPUS, Web of Knowledge and PsycInfo for papers comparing the neuropsychological performance of melancholic patients (MEL) to non-melancholic depressive patients (NMEL), including atypical depressives, and healthy controls (HC). All studies were scrutinised to determine the main methodological characteristics and particularly possible sources of bias influencing the results reported, using the STROBE statement checklist. We also provide effect size of the results reported for contrasts between MEL; patients and NMEL patients. Seventeen studies were included; most of them demonstrated higher neuropsychological impairments of MEL patients compared to both NMEL patients and HC on tasks requiring memory, executive function, attention and reaction time. Detailed analysis of the methodologies used in the studies revealed significant variability especially regarding the participants' sociodemographic characteristics, clinical characteristics of patients and differences in neuropsychological assessment. These findings suggest that MEL may have a distinct and impaired cognitive performance compared to NMEL depressive patients on tasks involving verbal and visual memory, executive function, sustained attention and span, as well as psychomotor speed, this last especially when cognitive load is increased. Additional studies with adequate control of potentially confounding variables will help to clarify further differences in the neuropsychological functioning of depressive subtypes.

Cluster analysis of cognitive performance in a sample of patients with Parkinson's disease / "Análise de Cluster" do desempenho cognitivo em uma amostra de pacientes com doença de Parkinson

ABSTRACT Background: Cognitive impairment is a common feature of Parkinson's disease (PD). The diagnoses of mild cognitive impairment (MCI) in patients with PD implies an increased risk for later development of dementia, however, it is unclear whether a specific type of cognitive loss confers increased risk for faster cognitive decline. Objective: Determine whether it was possible to identify distinct cognitive phenotypes in a sample of patients with PD. Methods: A cross-sectional evaluation of 100 patients with PD recruited from a movement disorders clinic was conducted. The patients were evaluated using the simplified motor score of the UPDRS, the Hoehn and Yahr, Schwab and England, Geriatric Depression Scale, Pfeffer Functional Activities Questionnaire, Clinical Dementia Rating Scale, Mini-Mental State Examination, clock drawing test, digit span, word list battery of CERAD, Frontal Assessment Battery and verbal fluency test. We classified the patients as having normal cognition (PDNC), MCI (PDMCI) or dementia (PDD). Data were analyzed using the chi-square test, non-parametric statistics and cluster analysis. Results: There were 40 patients with PDD, 39 with PDMCI and 21 with PDNC. Patients with PDD were older, had longer disease duration, lower education and lower MMSE scores. Cluster analysis showed 3 general distinct cognitive profiles that represented a continuum from mild to severe impairment of cognition, without distinguishing specific cognitive profiles. Conclusion: Cognitive impairment in PD occurs progressively and heterogeneously in most patients. It is unclear whether the definition of the initial phenotype of cognitive loss can be used to establish the cognitive prognosis of patients.

RESUMO Embasamento: O comprometimento cognitivo é um problema comum da doença de Parkinson (DP). O diagnóstico de comprometimento cognitivo leve (CCL) em pacientes com DP implica em risco aumentado para o desenvolvimento posterior de demência, no entanto, não é claro se algum tipo específico de perda cognitiva confere risco para um declínio cognitivo mais rápido. Objetivo: Determinar se seria possível identificar fenótipos cognitivos em uma amostra de pacientes com DP. Métodos: Foi uma avaliação transversal de 100 pacientes com DP recrutados de uma clínica de distúrbios de movimento. Eles foram avaliados utilizando um escore motor simplificado da UPDRS, Hoehn e Yahr, Schwab e England, Escala de Depressão Geriátrica, Questionário de Atividades Funcionais de Pfeffer, Escala CDR, Mini-Exame do Estado Mental, desenho do relógio, extensão de dígitos, lista de palavras da bateria do CERAD, bateria de avaliação frontal e teste de fluência verbal. Nós classificamos os pacientes como tendo cognição normal (PDCN), CCL (PDCCL) ou demência (PDD). Os dados foram analisados por meio do teste do qui-quadrado, estatística não-paramétrica e análise de cluster. Resultados: Havia 40 pacientes com PDD, 39 com PDCCL e 21 com PDCN. Pacientes com PDD eram mais velhos, tinham maior tempo de doença, menor escolaridade e desempenho inferior no MEEM. A análise de cluster mostrou 3 perfis cognitivos distintos que representariam um continuo entre discreto a grave comprometimento da cognição, sem distinguir perfis cognitivos específicos. Conclusão: O comprometimento cognitivo na DP ocorre de forma progressiva e heterogênea na maioria dos pacientes. Não é claro se a definição do fenótipo inicial de perda cognitiva poderia ser utilizado para estabelecer o prognóstico cognitivo para o paciente.

Some aspects of the validity of the Montreal Cognitive Assessment (MoCA)for evaluating cognitive impairment in Brazilian patients with Parkinson's disease / Alguns aspectos da validade da MoCA (Montreal Cognitive Assessment - MoCA) para avaliação de comprometimento cognitivo em pacientes brasileiros com doença de Parkinson

ABSTRACT Background: The Montreal Cognitive Assessment (MoCA) is a short global cognitive scale, and some studies suggest it is useful for evaluating cognition in patients with Parkinson's disease (PD). However, its accuracy has been questioned in studies involving patients with low education. Objective: We sought to assess whether some of the MoCA subtests contribute to the low accuracy of the test. Methods: We performed a cross-sectional retrospective analysis of clinical data in a cohort of 71 patients with PD, most with less than 8 years of education. Patients were examined using the MDS-UPDRS, Hoehn and Yahr and the MoCA. The data were analyzed using mainly descriptive statistics. Results: We analyzed the data of 66 patients that were not demented according to the clinical evaluation and classified them using the proposed cut-off MoCA scores for diagnosis of MCI and dementia. Thirteen patients (19.7%) were classified as having normal cognition, 24 (36.3%) MCI and 29 (43.9%) dementia. Patients with dementia had longer disease duration (p=0.016) and lower education (p=0.0001). Total MoCA scores had a an almost normal distribution with a wide range of scores and only one maximum score. Performance on the MoCA was highly correlated with education (correlation coefficient=0.66, p=0.0001). At least five of the 10 MoCA subtests showed significant floor effects. Conclusion: We believe that some of the MoCA subtests may be too difficult to be completed by PD patients with low educational level, thus contributing to the test's poor diagnostic accuracy.

RESUMO Embasamento: A MoCA é uma escala cognitiva global breve, e alguns estudos sugerem que ela seria útil para avaliar a cognição em pacientes com doença de Parkinson (DP). No entanto, sua acurácia foi questionada em estudos em pacientes com baixa escolaridade. Objetivo: Pretendeu-se avaliar se alguns dos subtestes da MoCA poderiam contribuir para a baixa precisão do teste. Métodos: Foi realizada uma análise transversal e retrospectiva de dados clínicos de uma coorte de 71 pacientes com DP, a maioria com menos de 8 anos de escolaridade. Os pacientes foram examinados usando o MDS-UPDRS, a Hoehn e Yahr e a MoCA. Os dados foram principalmente analisados pela estatística descritiva. Resultados: Foram analisados os dados de 66 pacientes que não foram diagnosticados com demência de acordo com a avaliação clínica. Eles foram em seguida classificados, usando as notas de corte MoCA propostos para diagnóstico de comprometimento cognitivo leve (CCL) e demência. Dessa forma, treze pacientes (19,7%) foram classificados como com a cognição normal, 24 pacientes (36,3%) com CCL e 29 pacientes (43,9%) como com demência. Os pacientes com demência tiveram maior duração da doença (p=0,016) e menor escolaridade (p=0,0001). A distribuição dos escores totais da MoCA apresentaram forma de distribuição normal com uma vasta gama de pontuações e apenas uma pontuação máxima. O desempenho no MoCA foi altamente correlacionado à escolaridade (coeficiente de correlação=0,66, p=0,0001). Pelo menos cinco dos 10 subtestes da MoCA mostraram efeitos piso significativos. Conclusão: Alguns dos subtestes MoCA podem ser muito difíceis de completar por pacientes com DP com baixa escolaridade, contribuindo assim para a baixa precisão diagnóstica do teste.

Cognitive deficits in chronic pain patients, in a brief screening test, are independent of comorbidities and medication use.

Objective To describe and analyze cognitive aspects in patients with chronic pain and a control group without pain. Method A case-control study was conducted on 45 patients with chronic pain and on 45 control subjects. Data including pain diagnosis, comorbidities and medication used, were evaluated. Cognitive tests, such as the Montreal Cognitive Assessment (MoCA), Verbal Fluency Test, Clock Drawing Test and Stroop Test, were applied. Results Patients with chronic pain showed a poorer performance, as shown by the scores of the MoCA test (p < 0.002), Verbal Fluency Test (p < 0.001), Clock Drawing Test (p = 0.022) and Stroop Test (p < 0.000). Chronic pain variable (p = 0.015, linear regression model) was an independent factor for results obtained with the MoCA. Conclusion Patients with chronic pain showed a poorer performance in a brief screening test for cognitive impairment not related to confounding variables, as comorbidities and pain-medication use.

Cognitive deficits in chronic pain patients, in a brief screening test, are independent of comorbidities and medication use / Déficits cognitivos em pacientes com dor crônica, em uma avaliação breve de triagem, são independentes de comorbidades e uso de medicações

ABSTRACT Objective To describe and analyze cognitive aspects in patients with chronic pain and a control group without pain. Method A case-control study was conducted on 45 patients with chronic pain and on 45 control subjects. Data including pain diagnosis, comorbidities and medication used, were evaluated. Cognitive tests, such as the Montreal Cognitive Assessment (MoCA), Verbal Fluency Test, Clock Drawing Test and Stroop Test, were applied. Results Patients with chronic pain showed a poorer performance, as shown by the scores of the MoCA test (p < 0.002), Verbal Fluency Test (p < 0.001), Clock Drawing Test (p = 0.022) and Stroop Test (p < 0.000). Chronic pain variable (p = 0.015, linear regression model) was an independent factor for results obtained with the MoCA. Conclusion Patients with chronic pain showed a poorer performance in a brief screening test for cognitive impairment not related to confounding variables, as comorbidities and pain-medication use.

RESUMO Objetivo Descrever e analisar aspectos cognitivos em pacientes com dor crônica e um grupo controle sem dor. Método Um estudo de caso-controle foi conduzido em 45 pacientes com dor crônica e 45 controles. Dados incluindo diagnóstico da dor, comorbidades e medicações utilizadas foram avaliados. Foram aplicados testes cognitivos, tais comoMontreal Cognitive Assessment, Teste da Fluência verbal, Teste do relógio e Teste de Stroop. Resultados Pacientes com dor crônica apresentaram uma pior performance, em scores do MoCA (p < 0.002), Fluência verbal (p < 0.001), Teste do relógio (p = 0.022) e Stroop (p < 0.000). Dor crônica (p = 0.015, modelo de regressão linear) foi um fator independente para os piores resultados obtidos no MoCA. Conclusão Pacientes com dor crônica apresentaram uma pior performance em uma avaliação breve para comprometimento cognitivo, não relacionada a variáveis confundidoras, como comorbidades e medicações utilizadas para dor.

The interlocking finger test in patients with Parkinson's disease and healthy subjects.

The interlocking finger test (ILFT) is a bedside screening test in which the subject must imitate four bimanual finger gestures without symbolic meaning. We assessed the utility of the test in the cognitive evaluation of patients with Parkinson's disease (PD). We evaluated 88 healthy subjects and 101 patients with PD using a simplified motor score of the Unified Parkinson's Disease Rating Scale (UPDRS), Hoehn and Yahr and Schwab and England scales, Geriatric Depression Scale, Pfeffer Functional Activities Questionnaire, Clinical Dementia Rating, Mini-Mental State Examination, clock drawing test, digit span, word list battery of the Consortium to Establish a Registry for Alzheimer's Disease assessment, Frontal Assessment Battery, semantic verbal fluency test, and the ILFT. Diagnoses of mild cognitive impairment and dementia were made using the Movement Disorder Society diagnostic criteria. ILFT scores in healthy subjects correlated significantly with age (p=0.001) and only one healthy subject scored 2 in the test. ILFT scores were significantly lower in patients with PD and dementia (p=0.001) and significantly correlated with cognitive and functional tests, but not with depressive symptoms (p=0.607), Hoehn and Yahr scores (p=0.907), or Schwab and England scores (p=0.701). Twenty-five patients with dementia, three patients with mild cognitive impairment, and six patients with apparently normal cognition scored less than 3 in the ILFT. The area under the receiver operating characteristic curve for the ILFT to discriminate patients with dementia from those without it was 0.76 (cut-off score of 3/2: sensitivity of 61%, specificity of 0.85). In conclusion, the ILFT seems to be a useful bedside test to assess cognitive impairment in patients with PD.